Ramipril Capsule
Product Images NDC 70518-4604

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 70518-4604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Ramipril 2.5mg 70518 4604 00)

Ramipril 2.5 mg capsule box label showing quantity of 50 capsules per box. The label includes NDC 70518-4604-00, indicates the capsule color as orange, and specifies RemedyRepack Inc. as the repackager located in Indiana, PA. Manufacturer information from Rising Pharma, Inc., Allendale, NJ, is present along with storage instructions and a QR code.*

FDA Label Image

Remedy_label (Remedy Label)

Label of Ramipril 2.5 mg oral capsule, quantity 1 capsule, manufactured by RemedyRepack Inc. The label includes storage instructions, a QR code, and a note that it is for prescription use only. The capsule color is indicated as orange.*

FDA Label Image

Figure 1 (Ramipril Fig1)

A line graph showing the proportion of patients over days of follow-up comparing Ramipril and Placebo groups. The x-axis represents days of follow-up up to about 1600, and the y-axis shows the proportion of patients up to 0.20. The graph includes a p-value of 0.0001 indicating statistical significance.*

FDA Label Image

Figure 2 (Ramipril Fig2)

A forest plot chart showing relative risk in the Ramipril group versus placebo across several patient subgroups. The chart lists subgroups including cardiovascular disease, diabetes, age, sex, hypertension, coronary artery disease history, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The horizontal axis represents relative risk with 95% confidence intervals, indicating incidence of composite outcomes in the placebo group for each subgroup.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure of Ramipril, depicted as a molecular diagram showing its chemical bonds and atomic arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.